SPEARHEAD-1: A PHASE 2 TRIAL OF AFAMITRESGENE AUTOLEUCEL (FORMERLY ADP-A2M4) IN PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA

SAFETY AND EFFICACY OF THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 IN PATIENTS WITH CONVENTIONAL CHONDROSARCOMA: UPDATE FROM THE PHASE 1 EXPANSION COHORT

PHASE II STUDY OF ERIBULIN AND PEMBROLIZUMAB IN PATIENTS WITH METASTATIC SOFT TISSUE SARCOMA

PROSPECTIVE SINGLE-ARM CONTROLLED TRIAL OF 3-WEEK-COURSE HYPOFRACTIONATED PREOPERATIVE RADIOTHERAPY FOR SOFT TISSUE SARCOMA OF THE EXTREMITY OR TRUNK

METRONOMIC SIROLIMUS AND CYCLOPHOSPHAMIDE IN METASTATIC OR UNRESECTABLE CHONDROSARCOMA; RESULTS OF THE COSYMO PHASE II TRIAL

A PHASE IA/IB DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2-P53 ANTAGONIST BI 907828 IN PATIENTS WITH ADVANCED/METASTATIC SARCOMA

PHASE I TRIAL OF OLARATUMAB PLUS TRABECTEDIN IN ADVANCED SOFT-TISSUE SARCOMA PATIENTS: OLATRASTS, A SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) STUDY

DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: ANALYSIS FROM SCOUT TRIAL

TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL ANALYSIS OF PATIENT-REPORTED OUTCOMES BASED ON TREATMENT STRATEGIES FROM AN EU/US PROSPECTIVE REGISTRY

TK216 FOR EWING SARCOMA- INTERIM PHASE 1/2 RESULTS

FINAL ANALYSIS FROM AMPECT, AN OPEN-LABEL PHASE 2 REGISTRATION TRIAL OF NAB-SIROLIMUS FOR PATIENTS WITH ADVANCED MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMORS (PECOMA)

A PHASE 2 STUDY OF TALIMOGENE LAHERPAREPVEC, NIVOLUMAB AND TRABECTEDIN (TNT) IN ADVANCED SARCOMA

IMMUNE INFILTRATE IN PRIMARY HIGH-RISK SOFT TISSUE SARCOMAS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND SURGERY IN THE ISG-STS-1001 RANDOMISED TRIAL: A PROGNOSTIC STUDY

HEALTH-RELATED QUALITY OF LIFE PREDICTS 1-YEAR-SURVIVAL IN SARCOMA PATIENTS - RESULTS OF A GERMAN OBSERVATIONAL STUDY

A RANDOMIZED PHASE 2 STUDY OF NIVOLUMAB MONOTHERAPY OR NIVOLUMAB COMBINED WITH IPILIMUMAB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS